BIOMAT Database Logo BIOMAT Database Logo

Cefoxitin, a semi-synthetic cephamycin: a microbiological overview. 1978

J Birnbaum, and E O Stapley, and A K Miller, and H Wallick, and D Hendlin, and H B Woodruff

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002440 Cefoxitin A semisynthetic cephamycin antibiotic resistant to beta-lactamase. Cefoxitin Sodium,MK-306,Mefoxin,Mefoxitin,Méfoxin,MK 306,MK306,Sodium, Cefoxitin
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D002513 Cephamycins Naturally occurring family of beta-lactam cephalosporin-type antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms. Antibiotics, Cephamycin,Cephamycin,Cephamycin Antibiotics
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000693 Anaerobiosis The complete absence, or (loosely) the paucity, of gaseous or dissolved elemental oxygen in a given place or environment. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Anaerobic Metabolism,Anaerobic Metabolisms,Anaerobioses,Metabolism, Anaerobic,Metabolisms, Anaerobic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D055598 Chemical Phenomena The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes. Chemical Concepts,Chemical Processes,Physical Chemistry Concepts,Physical Chemistry Processes,Physicochemical Concepts,Physicochemical Phenomena,Physicochemical Processes,Chemical Phenomenon,Chemical Process,Physical Chemistry Phenomena,Physical Chemistry Process,Physicochemical Phenomenon,Physicochemical Process,Chemical Concept,Chemistry Process, Physical,Chemistry Processes, Physical,Concept, Chemical,Concept, Physical Chemistry,Concept, Physicochemical,Concepts, Chemical,Concepts, Physical Chemistry,Concepts, Physicochemical,Phenomena, Chemical,Phenomena, Physical Chemistry,Phenomena, Physicochemical,Phenomenon, Chemical,Phenomenon, Physicochemical,Physical Chemistry Concept,Physicochemical Concept,Process, Chemical,Process, Physical Chemistry,Process, Physicochemical,Processes, Chemical,Processes, Physical Chemistry,Processes, Physicochemical

Related Publications

J Birnbaum, and E O Stapley, and A K Miller, and H Wallick, and D Hendlin, and H B Woodruff
An in vivo comparison of cefoxitin, a semi-synthetic cephamycin, with cephalothin.
January 1974, The Journal of antibiotics,
J Birnbaum, and E O Stapley, and A K Miller, and H Wallick, and D Hendlin, and H B Woodruff
Cefoxitin, a semi-synthetic cephamycin antibiotic. Metabolism in rats with renal insufficiency.
January 1978, Arzneimittel-Forschung,
J Birnbaum, and E O Stapley, and A K Miller, and H Wallick, and D Hendlin, and H B Woodruff
[Cefoxitin, a new partly synthetic cephamycin antibiotic].
January 1979, Die Medizinische Welt,
J Birnbaum, and E O Stapley, and A K Miller, and H Wallick, and D Hendlin, and H B Woodruff
Cefoxitin, a new semi-synthetic cephamycin: an in-vitro and in-vivo comparison with cephalothin.
December 1973, British medical journal,
J Birnbaum, and E O Stapley, and A K Miller, and H Wallick, and D Hendlin, and H B Woodruff
Cefoxitin, a semisynthetic cephamycin antibiotic: susceptibility studies.
January 1974, Antimicrobial agents and chemotherapy,
J Birnbaum, and E O Stapley, and A K Miller, and H Wallick, and D Hendlin, and H B Woodruff
Cefoxitin, a semisynthetic cephamycin antibiotic: in vivo evaluation.
January 1974, Antimicrobial agents and chemotherapy,
J Birnbaum, and E O Stapley, and A K Miller, and H Wallick, and D Hendlin, and H B Woodruff
Clinical use of cefoxitin, a new semisynthetic cephamycin.
July 1978, The New Zealand medical journal,
J Birnbaum, and E O Stapley, and A K Miller, and H Wallick, and D Hendlin, and H B Woodruff
[Microbiological evaluation of cefoxitin, a new beta-lactamase resistant cephamycin antibiotic, compared to cephalothin, cephaloridine and cefazolin].
August 1978, Fortschritte der Medizin,
J Birnbaum, and E O Stapley, and A K Miller, and H Wallick, and D Hendlin, and H B Woodruff
Cefoxitin, a semisynthetic cephamycin antibiotic: resistance to beta-lactamase inactivation.
January 1974, Antimicrobial agents and chemotherapy,
J Birnbaum, and E O Stapley, and A K Miller, and H Wallick, and D Hendlin, and H B Woodruff
Results of a clinical trial of cefoxitin, a new cephamycin antibiotic.
November 1977, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!